Back to mobile site

PDL BioPharma (PDLI) Reports Q3 Results; Guide

November 2, 2006 5:12 PM EST Send to a Friend
PDL BioPharma (Nasdaq: PDLI) reports Q3 earnings of $0.23 per share ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login